Atlas Venture Advisors, Inc. - Q1 2022 holdings

$464 Million is the total value of Atlas Venture Advisors, Inc.'s 7 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .

 Value Shares↓ Weighting
IAS  INTEGRAL AD SCIENCE HLDNG CO$313,574,000
-37.9%
22,722,7710.0%67.53%
-3.7%
DKNG  DRAFTKINGS INC$127,638,000
-29.1%
6,555,6080.0%27.49%
+9.8%
SNAP  SNAP INCcl a$8,838,000
-23.5%
245,5590.0%1.90%
+18.6%
ROKU  ROKU INC$7,229,000
-45.1%
57,7070.0%1.56%
-14.9%
VRDN  VIRIDIAN THERAPEUTICS INC$3,874,000
-6.5%
209,5050.0%0.83%
+44.8%
FSTX  F-STAR THERAPEUTICS INC$2,041,000
-29.3%
574,9960.0%0.44%
+9.7%
LRMR  LARIMAR THERAPEUTICS INC$1,183,000
-62.5%
292,1840.0%0.26%
-41.8%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SNAP INC20Q3 20236.1%
ROKU INC16Q3 202311.7%
LARIMAR THERAPEUTICS INC14Q3 20231.4%
TRANSLATE BIO INC11Q2 202152.9%
INTEGRAL AD SCIENCE HLDNG CO10Q3 202371.2%
BICYCLE THERAPEUTICS PLC10Q3 202125.2%
VIRIDIAN THERAPEUTICS INC10Q1 20232.1%
F-STAR THERAPEUTICS INC9Q4 20221.3%
DRAFTKINGS INC8Q1 202282.5%
MIRAGEN THERAPEUTICS INC8Q3 20205.0%

View Atlas Venture Advisors, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-02
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-08
13F-HR2023-01-31
13F-HR2022-11-10
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-01-27
13F-HR2021-11-04

View Atlas Venture Advisors, Inc.'s complete filings history.

Compare quarters

Export Atlas Venture Advisors, Inc.'s holdings